S&P 500   3,854.80 (-0.40%)
DOW   31,505.31 (+0.36%)
QQQ   313.54 (-1.53%)
AAPL   123.99 (-0.90%)
MSFT   229.74 (-1.77%)
FB   257.52 (-0.57%)
GOOGL   2,031.76 (-1.58%)
TSLA   681.57 (-0.71%)
AMZN   3,042.35 (-1.69%)
NVDA   520.26 (-2.98%)
BABA   237.14 (+1.16%)
CGC   33.91 (-3.80%)
GE   13.58 (+4.62%)
MU   91.48 (+0.43%)
NIO   42.96 (-0.76%)
AMD   82.49 (-1.95%)
T   28.52 (+1.06%)
F   12.35 (-1.59%)
ACB   10.66 (-3.35%)
DIS   194.85 (+0.47%)
BA   234.66 (+5.16%)
NFLX   527.14 (-3.77%)
PFE   34.17 (+1.97%)
S&P 500   3,854.80 (-0.40%)
DOW   31,505.31 (+0.36%)
QQQ   313.54 (-1.53%)
AAPL   123.99 (-0.90%)
MSFT   229.74 (-1.77%)
FB   257.52 (-0.57%)
GOOGL   2,031.76 (-1.58%)
TSLA   681.57 (-0.71%)
AMZN   3,042.35 (-1.69%)
NVDA   520.26 (-2.98%)
BABA   237.14 (+1.16%)
CGC   33.91 (-3.80%)
GE   13.58 (+4.62%)
MU   91.48 (+0.43%)
NIO   42.96 (-0.76%)
AMD   82.49 (-1.95%)
T   28.52 (+1.06%)
F   12.35 (-1.59%)
ACB   10.66 (-3.35%)
DIS   194.85 (+0.47%)
BA   234.66 (+5.16%)
NFLX   527.14 (-3.77%)
PFE   34.17 (+1.97%)
S&P 500   3,854.80 (-0.40%)
DOW   31,505.31 (+0.36%)
QQQ   313.54 (-1.53%)
AAPL   123.99 (-0.90%)
MSFT   229.74 (-1.77%)
FB   257.52 (-0.57%)
GOOGL   2,031.76 (-1.58%)
TSLA   681.57 (-0.71%)
AMZN   3,042.35 (-1.69%)
NVDA   520.26 (-2.98%)
BABA   237.14 (+1.16%)
CGC   33.91 (-3.80%)
GE   13.58 (+4.62%)
MU   91.48 (+0.43%)
NIO   42.96 (-0.76%)
AMD   82.49 (-1.95%)
T   28.52 (+1.06%)
F   12.35 (-1.59%)
ACB   10.66 (-3.35%)
DIS   194.85 (+0.47%)
BA   234.66 (+5.16%)
NFLX   527.14 (-3.77%)
PFE   34.17 (+1.97%)
S&P 500   3,854.80 (-0.40%)
DOW   31,505.31 (+0.36%)
QQQ   313.54 (-1.53%)
AAPL   123.99 (-0.90%)
MSFT   229.74 (-1.77%)
FB   257.52 (-0.57%)
GOOGL   2,031.76 (-1.58%)
TSLA   681.57 (-0.71%)
AMZN   3,042.35 (-1.69%)
NVDA   520.26 (-2.98%)
BABA   237.14 (+1.16%)
CGC   33.91 (-3.80%)
GE   13.58 (+4.62%)
MU   91.48 (+0.43%)
NIO   42.96 (-0.76%)
AMD   82.49 (-1.95%)
T   28.52 (+1.06%)
F   12.35 (-1.59%)
ACB   10.66 (-3.35%)
DIS   194.85 (+0.47%)
BA   234.66 (+5.16%)
NFLX   527.14 (-3.77%)
PFE   34.17 (+1.97%)
Log in

Piper Jaffray Companies's rating of Revance Therapeutics, Inc. on 9/17/2018

unlock icon Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.